FMR Global Research

Insights 

Aesthetics season 1 episode 4

TRUST BEFORE TREATMENT

– INTENDERS

Intenders represent the highest-potential growth segment in the aesthetics market. They have not recently undergone qualifying aesthetic treatments, but they are highly interested in doing so and are actively considering treatment. However, many remain in the early stages of decision-making and need reassurance before taking action. They rely heavily on practitioner guidance, Google, clinic websites, reviews, and recommendations from friends and family, while valuing safety, quality, scientific evidence, and personalized treatment. Rather than seeking dramatic transformation, they are looking for confidence, trust, and clear guidance to help them choose the right treatment and provider. They represent one of the greatest opportunities for brands and clinics to convert interest into long-term patient relationships.

Aesthetics season 1 episode 4

TRUST BEFORE TREATMENT

– LIGHT / OCCASIONAL USERS

Light / Occasional Users represent the least committed segment of the aesthetics market. They typically undergo a single treatment each year, make decisions on a case-by-case basis, and are still exploring the category rather than following a structured treatment journey. They rely less on practitioner guidance, are more influenced by friends and family, and place less importance on brands, scientific evidence, and premium-quality treatments. More cautious than Moderate or Heavy Users, they need reassurance, accessible education, and confidence-building experiences before becoming regular aesthetic patients.

Aesthetics season 1 episode 4

Trust Before
Treatment

– Moderate users

Moderate Users are the foundation of today’s aesthetics market. They follow structured treatment plans, trust practitioners and clinics, and combine professional guidance with their own research before making decisions. They value quality, safety, and proven results while remaining open to education through both digital and clinical channels. More engaged than occasional users but less committed than Heavy Users, they represent the largest opportunity for brands and clinics to build long-term patient relationships.

Aesthetics season 1 episode 4

Trust Before
Treatment

– Heavy users

Heavy Users are not simply frequent aesthetic patients—they represent the most committed and practitioner-led consumers in the category. Their decisions are driven by long-term treatment planning, trusted clinical relationships, and confidence in professional expertise rather than one-off procedures. With the highest treatment frequency, strongest future intent, and greatest emphasis on safety, quality, and brand credibility, they view aesthetics as an ongoing investment rather than a cosmetic purchase. Understanding this mindset reveals that lasting loyalty is built through trust, structured care, and consistent treatment experiences long before the next appointment.

Aesthetics season 1 episode 4

COMFORT ISN’T JUST ABOUT PAIN

Experience & Comfort Seekers are not simply looking for results. They evaluate aesthetic treatments through the lens of reassurance, trust, and overall experience. Their decisions are shaped by practitioner guidance, manageable treatment journeys, and confidence throughout the process. While they engage with digital content and research, emotional comfort often matters more than detailed evaluation. Understanding this mindset reveals why the treatment experience can be just as important as the outcome.

Aesthetics season 1 episode 4

VALUE ISN’T
ALWAYS ABOUT
PRICE

Value Sensitive users are not necessarily looking for the cheapest treatment. They evaluate aesthetic decisions through a value-for-money lens, weighing cost against expected results, treatment longevity, and return on investment. Their choices are guided by comparative research, perceived durability, and whether outcomes justify the investment. Understanding this mindset reveals why value perception often matters more than price alone.

Aesthetics season 1 episode 4

KNOWLEDGE GAPS
SHAPE AESTHETIC DECISIONS

Knowledge Gap users are not necessarily resistant to aesthetic treatments. They are interested, but uncertain about who to trust, which treatment is right, and what outcomes to expect. Their choices are guided by education, practitioner reassurance, and trusted information sources. Understanding these knowledge gaps reveals how confidence is built before patients move forward.

 

Aesthetics season 1 episode 4

FEAR ISN’T
ALWAYS
VISIBLE

Fear-driven patients are not necessarily resistant to aesthetic treatments. They are seeking reassurance. Their choices are guided by confidence in practitioner expertise, treatment safety, and predictable outcomes. Understanding these concerns reveals how trust is built and why some patients move forward while others remain hesitant.

Aesthetics season 1 episode 2.

WHO REALLY
DRIVES THE
AESTHETIC
DECISION?

75% of patients say brand matters, but only 6% actually choose based on it. Our latest insights from 1000+ consumers across global markets reveal that aesthetic decisions are still primarily driven by practitioner trust rather than brand influence. Patients associate brands with safety, quality, and reassurance, but when making final treatment decisions, they rely most on practitioners, consultations, and expert endorsement. Patients create the demand, practitioners shape the decision, and brands reinforce trust.

The Aesthetics Market Is No Longer About Single Concerns

THE AESTHETICS MARKET IS NO LONGER ABOUT SINGLE CONCERNS

Patients are not simply looking for “younger skin.” They are looking for confidence, reassurance, and visible but natural outcomes. Our latest insights from 1000+ consumers across global markets show that aesthetic decisions are moving beyond isolated concerns like wrinkles, sagging, acne, or pigmentation. Patients now think in broader concern ecosystems, combining skin quality, aging, firmness, hydration, and emotional outcomes into one treatment journey.

Optimizing Breastfeeding with the Latest Pumping Technology

The Symphony PLUS® program, developed for milk expression and breast stimulation during the first days after birth, is designed to support mothers by mimicking a newborn’s natural sucking rhythm. Medela’s extensive research has led to the development of advanced technologies like the 2-Phase Expression® Technology, which enhances milk supply. The Symphony breast pump, used in hospitals worldwide, ensures comfort and effectiveness, aiding mothers in building and maintaining their milk supply during early breastfeeding stages.

Preserving Breastfeeding During the COVID-19 Pandemic – Market Research Project

The COVID-19 pandemic has severely disrupted maternity services and breastfeeding support worldwide. Fear of infection, confusion due to changing guidelines, and strained healthcare resources have led to reduced in-hospital breastfeeding support, earlier discharges, and increased use of formula substitutes. Despite mothers’ willingness to breastfeed and continued recommendations from healthcare professionals, the challenges posed by the pandemic have jeopardized essential elements for establishing and maintaining milk supply. Healthcare professionals are urged to protect and promote breastfeeding through continuous support, both in hospitals and at home, to mitigate the long-term impact of these disruptions.

Real-World Use of Bedinvetmab for Canine Osteoarthritis in Europe

Bedinvetmab (Librela®), a novel treatment for canine osteoarthritis (OA), has shown significant effectiveness across five European countries. In a study with over 1,900 patient records, veterinarians reported a high satisfaction rate of 8.0 out of 10.0, with fewer than 1% discontinuing use due to dissatisfaction. Bedinvetmab reduced the need for multiple pharmacological treatments, with the proportion of dogs requiring additional medication for OA pain dropping from 47% to 31%. This new therapy offers hope for better pain management and improved quality of life for dogs suffering from OA.

Patient Preferences for Ulcerative Colitis Medication

A recent European survey conducted among ulcerative colitis patients and physicians highlights the importance of medication formulation on treatment adherence. The majority of patients preferred tablet formulations over granules, with 58% choosing tablets due to their ease of use and convenience. Physicians also favored tablets, believing that patients were more adherent and experienced better symptom relief compared to granules. However, both patients and physicians agreed that reducing the pill burden and simplifying dosing regimens would significantly improve adherence, particularly for those struggling with multiple daily doses.

Leveraging Marketing Studies for Strategic Pharmaceutical Publications

Many of our clients in the pharmaceutical industry utilize the marketing studies we conduct to enhance their market insights and communicate effectively with stakeholders. Our studies provide valuable quantitative and qualitative data, enabling pharmaceutical companies to understand current trends, emerging treatments, and industry dynamics. By publishing insights from these studies, clients strengthen their position as opinion leaders, address patient and healthcare professional needs, and bolster their scientific credibility. These publications not only showcase their market leadership but also help differentiate them in a highly competitive industry.

FMR Global Health is the health research arm of FMR Global Research

X